Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 12, 2000, Pages 2369-2377

  Patel, Rajnikant ^a   Lim, Do Sun ^a   Reddy, Deepa ^a   Nagueh, Sherif F ^a   Lutucuta, Sylvia ^a   Sole, Michael J ^b   Zoghbi, William A ^a   Quiñones, Miguel A ^a   Roberts, Robert ^a   Marian, Ali J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cytokines; Genes; Growth factors; Hypertrophy; Polymorphism

Indexed keywords

ALDOSTERONE SYNTHASE; INTERLEUKIN 6; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0034502439     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1267     Document Type: Article

References (46)

1. Molecular genetic studies of familial hypertrophic cardiomyopathy
2. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
3. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
4. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations
5. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
6. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations
7. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
8. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy
9. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy
10. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
11. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy
12. Heritability of cardiac size: An echocardiographic and electrocardiographic study of monozygotic and dizygotic twins
13. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension
14. Overexpression of transforming growth factor-beta 1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy
15. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
16. Tumor necrosis factoralpha provokes a hypertrophic growth response in adult cardiac myocytes
17. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function
18. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
19. The TGF beta superfamily in myocardium: Ligands, receptors, transduction, and function
20. An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs
21. A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus
22. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms
23. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
24. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
25. Genetic control of the circulating concentration of transforming growth factor type beta 1
26. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males
27. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
28. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
29. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNFalpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production
30. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
31. The tumor necrosis factor ligand and receptor families
32. The biology of cachectin/TNFa primary mediator of the host response
33. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes
34. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles
35. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism
36. Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene
37. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
38. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
39. Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts
40. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I
41. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure
42. Leukemia inhibitory factor and interleukin-6 downregulate sarcoplasmic reticulum Ca2 + ATPase (SERCA2) in cardiac myocytes
43. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes
44. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation
45. An interleukin-6 secreting myxoma in a hypertrophic left ventricle